The Biologic Alternative Already Trusted Worldwide: What American Patients Should Understand About Biosimilars
Biosimilars—rigorously tested, FDA-approved alternatives to some of the most expensive biologic medications on the market—have been standard treatment options in Europe and parts of Asia for over a decade. Yet in the United States, adoption remains stubbornly low, leaving millions of patients paying far more than necessary for drugs that treat rheumatoid arthritis, certain cancers, inflammatory bowel disease, and diabetes.